$0.00
80.00% yesterday
Nasdaq, Aug 25, 04:38 pm CET
ISIN
US67011T2015
Symbol
NVOS

Novo Integrated Sciences Inc Stock price

$0.00
-0.00 72.73% 1M
-0.05 98.36% 6M
-0.05 98.27% YTD
-1.50 99.94% 1Y
-16.50 99.99% 3Y
-48.00 100.00% 5Y
-8.00 99.99% 10Y
-4,000.00 100.00% 20Y
Nasdaq, Closing price Mon, Aug 25 2025
+0.00 80.00%

Key metrics

Basic
Market capitalization
$10.0k
Enterprise Value
$3.3m
Net debt
$3.3m
Cash
$840.0k
Shares outstanding
19.1m
Valuation (TTM | estimate)
P/E
negative | -
P/S
0.0 | -
EV/Sales
0.3 | -
EV/FCF
negative
P/B
0.0
Financial Health
Equity Ratio
46.3%
Return on Equity
-108.6%
ROCE
-47.4%
ROIC
-36.0%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$13.3m | -
EBITDA
$-6.1m | -
EBIT
$-8.3m | -
Net Income
$-16.2m | -
Free Cash Flow
$-5.1m
Growth (TTM | estimate)
Revenue
5.7% | -
EBITDA
3.2% | -
EBIT
2.8% | -
Net Income
-22.3% | -
Free Cash Flow
-121.4%
Margin (TTM | estimate)
Gross
43.2%
EBITDA
-45.5% | -
EBIT
-62.5%
Net
-121.6% | -
Free Cash Flow
-38.2%
More
EPS
$-0.8
FCF per Share
$-0.3
Short interest
1.5%
Employees
190
Rev per Employee
$70.0k
Show more

Is Novo Integrated Sciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Financial data from Novo Integrated Sciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
13 13
6% 6%
100%
- Direct Costs 7.55 7.55
1% 1%
57%
5.74 5.74
16% 16%
43%
- Selling and Administrative Expenses 14 14
4% 4%
106%
- Research and Development Expense - -
-
-
-6.05 -6.05
3% 3%
-46%
- Depreciation and Amortization 2.26 2.26
2% 2%
17%
EBIT (Operating Income) EBIT -8.31 -8.31
3% 3%
-63%
Net Profit -16 -16
22% 22%
-122%

In millions USD.

Don't miss a Thing! We will send you all news about Novo Integrated Sciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

Head office United States
CEO Robert Mattacchione
Employees 190
Founded 2000
Website www.novointegrated.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today